Ethanol, Thyroid Hormones and Acute Liver Injury: Is There a Relationship?
1983; Lippincott Williams & Wilkins; Volume: 3; Issue: 4 Linguagem: Inglês
10.1002/hep.1840030420
ISSN1527-3350
AutoresAndrew Szilagyi, Sam Lerman, Robert H. Resnick,
Tópico(s)Drug-Induced Hepatotoxicity and Protection
ResumoHepatologyVolume 3, Issue 4 p. 593-600 Special ArticlesFree Access Ethanol, Thyroid Hormones and Acute Liver Injury: Is There a Relationship? Andrew Szilagyi, Corresponding Author Andrew Szilagyi Departments of Medicine, Gastroenterology, and Endocrinology, Reddy Memorial Hospital; Montreal, Quebec, Canada H3Z 1T5; Sir Mortimer B. Davis Jewish General Hospital and McGill University, Montreal, Quebec, Canada H3T1E2; Department of Medicine and Gastroenterology, Lemuel Shattuck Hospital and Tufts University, Boston, Massachusetts 02130Andrew Szilagyi, M.D., 6000 Cǒte des Neiges, Suite 245, Montreal, Quebec, Canada H3S 1Z8.===Search for more papers by this authorSam Lerman, Sam Lerman Departments of Medicine, Gastroenterology, and Endocrinology, Reddy Memorial Hospital; Montreal, Quebec, Canada H3Z 1T5; Sir Mortimer B. Davis Jewish General Hospital and McGill University, Montreal, Quebec, Canada H3T1E2; Department of Medicine and Gastroenterology, Lemuel Shattuck Hospital and Tufts University, Boston, Massachusetts 02130Search for more papers by this authorRobert H. Resnick, Robert H. Resnick Departments of Medicine, Gastroenterology, and Endocrinology, Reddy Memorial Hospital; Montreal, Quebec, Canada H3Z 1T5; Sir Mortimer B. Davis Jewish General Hospital and McGill University, Montreal, Quebec, Canada H3T1E2; Department of Medicine and Gastroenterology, Lemuel Shattuck Hospital and Tufts University, Boston, Massachusetts 02130Search for more papers by this author Andrew Szilagyi, Corresponding Author Andrew Szilagyi Departments of Medicine, Gastroenterology, and Endocrinology, Reddy Memorial Hospital; Montreal, Quebec, Canada H3Z 1T5; Sir Mortimer B. Davis Jewish General Hospital and McGill University, Montreal, Quebec, Canada H3T1E2; Department of Medicine and Gastroenterology, Lemuel Shattuck Hospital and Tufts University, Boston, Massachusetts 02130Andrew Szilagyi, M.D., 6000 Cǒte des Neiges, Suite 245, Montreal, Quebec, Canada H3S 1Z8.===Search for more papers by this authorSam Lerman, Sam Lerman Departments of Medicine, Gastroenterology, and Endocrinology, Reddy Memorial Hospital; Montreal, Quebec, Canada H3Z 1T5; Sir Mortimer B. Davis Jewish General Hospital and McGill University, Montreal, Quebec, Canada H3T1E2; Department of Medicine and Gastroenterology, Lemuel Shattuck Hospital and Tufts University, Boston, Massachusetts 02130Search for more papers by this authorRobert H. Resnick, Robert H. Resnick Departments of Medicine, Gastroenterology, and Endocrinology, Reddy Memorial Hospital; Montreal, Quebec, Canada H3Z 1T5; Sir Mortimer B. Davis Jewish General Hospital and McGill University, Montreal, Quebec, Canada H3T1E2; Department of Medicine and Gastroenterology, Lemuel Shattuck Hospital and Tufts University, Boston, Massachusetts 02130Search for more papers by this author First published: 1983 https://doi.org/10.1002/hep.1840030420Citations: 13AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Galambos JT. Cirrhosis major problems in internal medicine. In: LH Smith, ed., Vol XVII. Philadelphia: W. B. Saunders Co., 1979: 91–127. Google Scholar 2 Best CH, Huntsman, ME. The effect of the components of leci-thine upon deposition of fat in the liver. J Physiol 1932; 75: 405–412. 10.1113/jphysiol.1932.sp002899 CASPubMedWeb of Science®Google Scholar 3 Best CH, Ridout JH. Lipotropic action of methionine. J Physiol 1940; 97: 489–494. 10.1113/jphysiol.1940.sp003824 CASPubMedGoogle Scholar 4 Popper H, Schaffner F. Nutritional cirrhosis in man? N Engl J Med 1971; 285: 577–578. 10.1056/NEJM197109022851010 CASPubMedWeb of Science®Google Scholar 5 Patek AJ, Toth IG, Saunders MG, et al. Alcohol and dietary factors in cirrhosis. Arch Intern Med 1975; 135: 1053–1057. PubMedWeb of Science®Google Scholar 6 Sorell MF, Leevy CM. Lymphocyte transformation and alcoholic liver injury. Gastroenterology 1972; 63: 1020–1025. PubMedWeb of Science®Google Scholar 7 Mihas AA, Bull DM, Davidson CS. Cell mediated immunity to liver in patients with alcoholic hepatitis. Lancet 1975; 1: 951–952. 10.1016/S0140-6736(75)92009-7 CASPubMedWeb of Science®Google Scholar 8 Zetterman RK, Luisada-Opper A, Leevy CM. Alcoholic hepatitis cell-mediated immunological response to alcoholic hyalin. Gastroenterology 1975; 70: 382–384. PubMedWeb of Science®Google Scholar 9 Kakuma S, Leevy CM. Lymphocyte cytotoxicity in alcoholic hepatitis. Gastroenterology 1977; 72: 594–597. PubMedWeb of Science®Google Scholar 10 Cochrane AMS, Moussouros A, Portmann B, et al. Lymphocyte cytotoxicity for isolated hepatocytes in alcoholic liver disease. Gastroenterology 1977; 72: 918–923. PubMedWeb of Science®Google Scholar 11 Actis GC, Ponzetto A, Rizzetto M, et al. Cell-mediated immunity to acetaldehyde in alcoholic liver disease demonstrated by leukocyte migration test. Dig Dis 1978; 23: 883–886. 10.1007/BF01072460 PubMedWeb of Science®Google Scholar 12 Popper H, Lieber CS. Histogenesis of alcoholic fibrosis and cirrhosis in the baboon. Am J Pathol 1980; 98: 695–710. CASPubMedWeb of Science®Google Scholar 13 Kakuma S, Leevy CM, Frank O, et al. Protection of pyridoxal 5′-phosphate against toxicity of acetaldehyde to hepatocytes. Pro Soc Exp Biol Med 1981; 168: 325–329. 10.3181/00379727-168-41280 CASPubMedWeb of Science®Google Scholar 14 Lieber CS. Liver adaption and injury in alcoholism. N Engl J Med 1973; 288: 356–361. 10.1056/NEJM197302152880710 CASPubMedWeb of Science®Google Scholar 15 Geokas MC, Lieber CS, French S, et al. Ethanol, the liver and gastrointestinal tract. Ann Intern Med 1981; 95: 198–211. 10.7326/0003-4819-95-2-198 CASPubMedWeb of Science®Google Scholar 16 Israel Y, Videla L, Bernstein J. Liver hypermetabolic state after chronic ethanol consumption: hormonal interrelations and pathogenic implications. Fed Proc 1975; 34: 2052–2059. CASPubMedWeb of Science®Google Scholar 17 Orrego H, Kalant H, Israel Y, et al. Effect of short-term therapy with propylthiouracil in patients with alcoholic liver disease. Gastroenterology 1979; 76: 105–115. PubMedWeb of Science®Google Scholar 18 Hallé P, Paré P, Kaptein E, et al. Double-blind, controlled trial of prophythiouracil in patients with severe acute alcoholic hepatitis. Gastroenterology 1982; 82: 925–931. PubMedWeb of Science®Google Scholar 19 Kater RMH, Carulli N, Iher F. Differences in the rate of ethanol metabolism in recently drinking alcoholic and nondrinking subjects. Am J Clin Nutr 1969; 22: 1608–1617. CASPubMedWeb of Science®Google Scholar 20 Misra PS, Lefévre A, Ishii H, et al. Increase of ethanol, mepro-bamate and pentobarbital metabolism after chronic ethanol administration in man and rats. Am J Med 1971; 51: 346–351. 10.1016/0002-9343(71)90270-1 CASPubMedWeb of Science®Google Scholar 21 Pieper WA, Skeen MJ. Changes in rate of ethanol elimination associated with chronic administration of ethanol to chimpanzees and rhesus monkeys. Drug Metab Dispos 1973; 1: 634–644. CASPubMedWeb of Science®Google Scholar 22 Tobon F, Mezey E. Effect of ethanol administration on hepatic ethanol and drug metabolizing enzymes and on rates of ethanol degradation. J Lab Clin Med 1971; 77: 110–121. CASPubMedWeb of Science®Google Scholar 23 Mezey E, Tobon F. Rates of ethanol clearance and activities of the ethanol-oxidizing enzymes in chronic alcoholic patients. Gastroenterology 1971; 61: 707–715. 10.1016/S0016-5085(19)33432-8 CASPubMedWeb of Science®Google Scholar 24 Ugarte G, Pereda T, Pino ME, et al. Influence of alcohol intake, length of abstinence and meprobamate on the rate of ethanol metabolism in man. Q J Stud Alcohol 1972; 33: 698–705. PubMedWeb of Science®Google Scholar 25 Ugarte G, Iturriaga H, Pereda T. Possible relationship between the rate of ethanol metabolism and the severity of hepatic damage in chronic alcoholics. Dig Dis 1977; 22: 406–410. 10.1007/BF01071886 CASPubMedWeb of Science®Google Scholar 26 Iturriaga H, Ugarte G, Israel Y. Hepatic vein oxygenation, liver blood flow, and the rate of ethanol metabolism in recently abstinent alcoholic patients. Eur J Clin Invest 1980; 10: 211–218. 10.1111/j.1365-2362.1980.tb00022.x CASPubMedWeb of Science®Google Scholar 27 Lieberman F. The effect of liver disease on the rate of ethanol metabolism in man. Gastroenterology 1963; 44: 261–266. 10.1016/S0016-5085(63)80134-1 CASPubMedWeb of Science®Google Scholar 28 Mikata A, Dimakulangan AA, Hartoft WS. Metabolism of ethanol in rats with cirrhosis: Gastroenterology 1963; 44: 159–167. 10.1016/S0016-5085(63)80008-6 CASPubMedWeb of Science®Google Scholar 29 Videla L, Israel Y. Factors that modify the metabolism of ethanol in rat liver and adaptive changes produced by its chronic administration. Biochem J 1970; 118: 275–281. 10.1042/bj1180275 CASPubMedWeb of Science®Google Scholar 30 Pirola RC, Lieber CS. Energy wastage in rats given drugs that induce microsomal enzymes. J Nutr 1975; 105: 1544–1548. 10.1093/jn/105.12.1544 CASPubMedWeb of Science®Google Scholar 31 Pirola RC, Lieber CS. Hypothesis: energy wastage in alcoholism and drug abuse: Possible role of hepatic microsomal enzymes. Am J Clin Nutr 1976; 29: 90–93. 10.1093/ajcn/29.1.90 CASPubMedWeb of Science®Google Scholar 32 Tremolieres J, Carre L. Etudes sur les modalités ďoxcydation de ľalcool chez ľhomme normal et alcoolique. Rev de ľAcoolisme 1961; 7: 202–227. CASGoogle Scholar 33 Arslanian MJ, Pascoe E, Reinhold JG. Rat liver alcohol dehydrogenase purification and properties. Biochem J 1971; 125: 1039–1047. 10.1042/bj1251039 CASPubMedWeb of Science®Google Scholar 34 Teschke R, Hasumura Y, Lieber CS. Hepatic ethanol metabolism: Respective roles of alcohol dehydrogenase, microsomal ethanol-oxidizing system and catalase. Arch Biochem Biophys 1976; 175: 635–643. 10.1016/0003-9861(76)90554-3 CASPubMedWeb of Science®Google Scholar 35 Lieber CS, De Carli LM. Ethanol oxidation by hepatic microsomes: adaptive increase after ethanol feeding. Science 1968; 162: 917–918. 10.1126/science.162.3856.917 CASPubMedWeb of Science®Google Scholar 36 Lieber CS, De Carli LM. Hepatic microsomal ethanol-oxidizing system in vitro characteristics and adaptive properties in vivo. J Biol Chem 1970; 245: 2505–2512. CASPubMedWeb of Science®Google Scholar 37 Redman CM, Grab DJ, Irukulla R. The intracellular pathways of newly formed rat liver catalase. Arch Biochem Biophys 1972; 152: 496–501. 10.1016/0003-9861(72)90244-5 CASPubMedWeb of Science®Google Scholar 38 Feytmans E, Leighton F. Effect of pyrazole and 3-amino-1,2-H-triazole on methanol and ethanol metabolism by the rat. Biochem Pharmacol 1973; 22: 349–360. 10.1016/0006-2952(73)90416-4 CASPubMedWeb of Science®Google Scholar 39 Pietruszko R, Theorell H, De Zalenski C. Heterogeneity of alcohol dehydrogenase from human livers. Arch Biochem Biophys 1972; 153: 270–293. 10.1016/0003-9861(72)90446-8 CASWeb of Science®Google Scholar 40 Li TK, Magnes LJ. Identification of a distinctive molecular form of alcohol dehydrogenase in human livers with high activity. Biochem Biophys Res Commun 1975; 63: 202–208. 10.1016/S0006-291X(75)80030-1 CASPubMedWeb of Science®Google Scholar 41 Bosron WF, Li TK, Lange LS, et al. Isolation and characterization of an anodic form of human liver alcohol dehydrogenase. Biochem Biophys Res Commun 1977; 74: 85–91. 10.1016/0006-291X(77)91378-X CASPubMedWeb of Science®Google Scholar 42 Li TK, Bosron WF, Dafeldecker WP, et al. Isolation of Il-alcohol dehydrogenase of human liver: is it a determinant of alcoholism? Proc Natl Acad Sci USA 1977; 74: 4378–4381. 10.1073/pnas.74.10.4378 CASPubMedWeb of Science®Google Scholar 43 Bosron WF, Li TK, Vallee BL. Heterogeneity and new molecular forms of human liver alcohol dehydrogenase. Biochem Biophys Res Commun 1979; 91: 1549–1555. 10.1016/0006-291X(79)91241-5 CASPubMedWeb of Science®Google Scholar 44 Bosron WF, Li TK, Vallee BL. New molecular forms of human liver alcohol dehydrogenase: isolation and characterization of ADH. Proc Natl Acad Sci USA 1980; 77: 5784–5788. 10.1073/pnas.77.10.5784 CASPubMedWeb of Science®Google Scholar 45 Asada M, Galambos JT. Liver disease, hepatic alcohol dehydrogenase activity and alcohol metabolism in the human. Gastroenterology 1973; 45: 67–72. Google Scholar 46 Wilson EC. Ethanol metabolism in mice with different levels of hepatic alcohol dehydrogenase. In: RP Maichel, eds. Biochemical factors in alcoholism, London: Pergamon Press, 1967: 115–124. Google Scholar 47 Ylikahri RH, Maenpaa PG. Rate of ethanol metabolism in fed and starved rats after thyroxine treatment. Acta Chem Scan 1968; 22: 1707–1709. 10.3891/acta.chem.scand.22-1707 CASPubMedWeb of Science®Google Scholar 48 Mezey E, Vestal RE, Potter JJ, et al. Effect of uremia on rates of ethanol disappearance from the blood and on the activities of the ethanol-oxidizing system. J Lab Clin Med 1975; 86: 931–937. CASPubMedWeb of Science®Google Scholar 49 Krebs HA, Stubbs M. Factors controlling the rate of alcohol disposal by the liver. Adv Exp Med Biol 1975; 59: 149–160. 10.1007/978-1-4757-0632-1_12 CASPubMedGoogle Scholar 50 Lieber CS. Medical disorders of alcoholism. Pathogenesis and treatment. In: LH Smith, ed. Major problems in internal medicine, Vol XXII. Philadelphia: W. B. Saunders, 1982: 1–42. Google Scholar 51 Crow KE, Cornell NW, Veech RL. The rate of ethanol metabolism in isolated rat hepatocytes. Alcoholism: Clin Exper Res 1977; 1: 43–47. 10.1111/j.1530-0277.1977.tb05765.x CASPubMedWeb of Science®Google Scholar 52 Lumeng L, Bosron WF, Li TK. Quantitative correlation of ethanol elimination rates in vivo with liver alcohol dehydrogenase activities in fed, fasted and food restricted rats. Biochem Pharmacol 1979; 28: 1547–1551. 10.1016/0006-2952(79)90471-4 CASPubMedWeb of Science®Google Scholar 53 Mezey LS, Potter JJ. Rat liver alcohol dehydrogenase activity. Effects of growth hormone and hypophysectomy. Endocrinology 1979; 104: 1667–1673. 10.1210/endo-104-6-1667 CASPubMedWeb of Science®Google Scholar 54 Mezey E, Potter JJ, Harmon SM, et al. Effects of castration and testosterone administration on rat liver alcohol dehydrogenase activity. Biochem Pharmacol 1980; 29: 3175–3180. 10.1016/0006-2952(80)90582-1 CASPubMedWeb of Science®Google Scholar 55 Mezey E, Potter JJ. Effects of thyroidectomy and triiodothyronine administration on rat live alcohol dehyrogenase. Gastroenterology 1981; 80: 566–574. 10.1016/0016-5085(81)90020-2 CASPubMedWeb of Science®Google Scholar 56 Thurman RS, McKenna WR, McCaffrey TB. Pathways responsible for the adaptive increase in ethanol utilization following chronic treatment with ethanol: inhibitor studies with the hemo-glogin-free perfused rat liver. Molec Pharmacol 1976; 12: 156–166. CASPubMedWeb of Science®Google Scholar 57 Orrego H, Israel Y, Blendis LM. Alcoholic liver disease: information in search of knowledge. Hepatology 1981; 1: 267–283. 10.1002/hep.1840010313 CASPubMedWeb of Science®Google Scholar 58 Edwards JA, Price-Evans DA. Ethanol metabolism in subjects possessing typical and atypical liver alcohol dehydrogenase. Clin Pharmacol Ther 1967; 8: 824–820. 10.1002/cpt196786824 CASPubMedWeb of Science®Google Scholar 59 Lehninger AL. Phosphorylation coupled to oxidation of dihydro-giphosphopyridine nucleotide. J Biochem 1951; 190: 345–359. CASPubMedWeb of Science®Google Scholar 60 Chappel JH. Systems used for the transport of substrates into mitochondria. Br Med Bull 1968; 24: 150–157. 10.1093/oxfordjournals.bmb.a070618 PubMedWeb of Science®Google Scholar 61 Chance B, Miatra PK. In: B Wright, ed. Control mechanisms in respiration and fermentation. New York: Ronald Press Co., 1963: 307–332. Google Scholar 62 Klingenberg M. The respiratory chain. In: TB Singer, ed. Biological oxidation. New York: Interscience, 1958: 3–49. Google Scholar 63 Gordon E. Mitochondrial functions in an ethanol induced fatty liver. J Biol Chem 1973; 248: 8271–8280. CASPubMedWeb of Science®Google Scholar 64 Videla L, Bernstein J, Israel Y. Metabolic alterations in the liver by chronic ethanol administration. Increased oxidative capacity. Biochem J 1973; 134: 507–514. 10.1042/bj1340507 CASPubMedWeb of Science®Google Scholar 65 Israel Y, Videla L, Macdonald A, et al. Metabolic alterations produced in the liver by chronic ethanol administration: comparison between the effects produced by ethanol and by thyroid hormones. Biochem J 1973; 134: 523–529. 10.1042/bj1340523 CASPubMedGoogle Scholar 66 Bernstein J, Videla L, Israel Y. Metabolic alterations produced in the liver by chronic ethanol administration. Changes related to energetic parameters of the cell. Biochem J 1973; 134: 515–521. 10.1042/bj1340515 CASPubMedWeb of Science®Google Scholar 67 Edmonson HA, Schiff L. Needle biopsy of the liver. In: L Schiff, ed. Diseases of the liver, 4th ed. Philadelphia: J. B. Lippincott Co., 1975: 247–271. Google Scholar 68 Rappaport AM. Liver architecture and microcirculation. In: JM Khanna, Y Israel, H Kalant, eds. Alcoholic liver pathology. Toronto: House of Lind, 1975: 43–67. Google Scholar 69 Israel Y, Kalant H, Orrego H, et al. Experimental alcohol-induced hepatic necrosis: suppression by propylthiouracil. Proc Natl Acad Sci USA 1975; 72: 1137–1141. 10.1073/pnas.72.3.1137 CASPubMedWeb of Science®Google Scholar 70 Israel Y, Orrego H, Khanna LM, et al. Alcohol induced susceptibility to hypoxic liver damage: possible role in the pathogenesis of alcohol liver disease? In: MM Fisher, JG Rankin, eds. Alcohol and the liver. New York: Plenum Publishing Co., 1977: 323–346. 10.1007/978-1-4613-4184-0_21 Google Scholar 71 Lieber CS, De Carli LM. Hepatic microsomal ethanol oxidizing system: in vitro characteristics and adaptive properties in vivo. J Biol Chem 1970; 245: 2505–2512. CASPubMedWeb of Science®Google Scholar 72 Salaspuro MP, Lindros LO, Pikkarainen P. Ethanol and galactose metabolism as influenced by 4-methylpyrazole in alcoholics with and without nutritional deficiencies. Preliminary report of a new approach to pathogenesis and treatment in alcoholic liver disease. Ann Clin Res 1975; 7: 269–272. CASPubMedWeb of Science®Google Scholar 73 Matsuzaki S, Teschke R, Ohnishi K, et al. Acceleration of ethanol concentrations and chronic ethanol consumption: role of the microsomal ethanol oxidizing system (MEOS). In: MM Fisher, JG Rankin, eds. Alcohol and the liver. New York: Plenum Publishing Co., 1977: 119–143. 10.1007/978-1-4613-4184-0_8 Google Scholar 74 Schaffer WT, Denckla WD, Veech RL. The effect of chronic ethanol consumption on the rate of whole animal and perfused liver oxygen consumption. Adv Exp Med Biol 1980; 132: 587–593. CASPubMedGoogle Scholar 75 Cederbaum AL, Dicker E, Lieber CS, et al. Ethanol oxidation by isolated hepatocytes from ethanol-treated and control rats: factors contributing to the metabolic adaptation after chronic ethanol consumption. Biochem Pharmacol 1978; 27: 7–15. 10.1016/0006-2952(78)90250-2 CASPubMedWeb of Science®Google Scholar 76 Gordon ER. ATP metabolism in an ethanol-induced fatty liver. Alcoholism: Clin Exp Res 1977; 1: 21–25. 10.1111/j.1530-0277.1977.tb05761.x CASPubMedWeb of Science®Google Scholar 77 Yuki T, Thurman RG, Schwabe U et al. Metabolic changes after prior treatment with ethanol. Evidence against an involvement of the Na+ – K+ activated ATPase in the increase in ethanol metabolism. Biochem J 1980; 186: 997–1000. 10.1042/bj1860997 CASPubMedWeb of Science®Google Scholar 78 Freund G. Possible relationships of alcohol in membranes to cancer. Cancer Res 1979; 39: 2899–2901. CASPubMedWeb of Science®Google Scholar 79 Rubin E, Rottenberg H. Ethanol injury and adaptation in biological membranes. Fed Proc 1982; 41: 2465–2471. CASPubMedWeb of Science®Google Scholar 80 Ricci RL, Crawford SG, Miner PB Jr. The effect of ethanol on hepatic sodium plus potassium activated adesine triphosphatase activity in the rat. Gastroenterology 1981; 80: 1445–1450. CASPubMedWeb of Science®Google Scholar 81 Lieber CS, Teschke R, Hasumura Y, et al. Differences in hepatic and metabolic changes after acute and chronic alcohol consumption. Fed Proc 1975; 34: 2060–2074. CASPubMedWeb of Science®Google Scholar 82 Singh SP, Snyder AK. Interaction of ethanol and thyroxine on hepatic oxygen consumption. Proc Soc Exp Biol Med 1978; 159: 226–229. 10.3181/00379727-159-40320 CASPubMedWeb of Science®Google Scholar 83 Barker SB, Klitgaard HM. Metabolism of tissues excised from thyroxine-injected rats. Am J Physiol 1952; 170: 81–86. CASPubMedWeb of Science®Google Scholar 84 Fullerton CW, Harrop GA Jr. The cardiac output in hyperthyroidism. Bull Johns Hopkins Hosp 1930; 46: 203–216. Google Scholar 85 Myers JD, Brannon ES, Holland BC. A correlative study of the cardiac output and the hepatic circulation in hyperthyroidism. J Clin Invest 1950; 29: 1069–1077. 10.1172/JCI102338 CASPubMedWeb of Science®Google Scholar 86 Lancestremere RG, Davidson PL, Early LE, et al. Renal failure in Laennec's cirrhosis. II. Simultaneous determination of cardiac output and renal hemodynamice. J Clin Invest 1962; 41: 1922–1927. 10.1172/JCI104649 CASPubMedWeb of Science®Google Scholar 87 Kontos HA, Shapiro W, Mauck HP, et al. General and regional circulatory alterations in cirrhosis of the liver. Am J Med 1964; 37: 526–535. 10.1016/0002-9343(64)90066-X PubMedWeb of Science®Google Scholar 88 Epstein M, Schneider N, Befeler B. Relationship of systemic and intrarenal hemodynamics in cirrhosis. J Lab Clin Med 1977; 89: 1175–1187. CASPubMedWeb of Science®Google Scholar 89 Ring-Larsen H, Heese B, Henriksen JH. Sympathetic nervous activity and renal and systemic hemodynamics in cirrhosis: plasma norepinephrine concentration, hepatic extraction and renal release. Hepatology 1982; 2: 304–310. 10.1002/hep.1840020303 PubMedWeb of Science®Google Scholar 90 Summerskill WHJ, Molnar GD. Eye signs in hepatic cirrhosis. N Engl J Med 1962; 266: 1244–1248. 10.1056/NEJM196206142662402 CASPubMedWeb of Science®Google Scholar 91 Flock EV, Owen CA Jr. Metabolism of thyroid hormones and some derivatives in isolated, perfused rat liver. Am J Physiol 1965; 209: 1039–1045. CASPubMedWeb of Science®Google Scholar 92 Kaplan MM, Utiger RD. Iodothyronine metabolism in rat liver homogenates. J Clin Invest 1978; 61: 459–471. 10.1172/JCI108957 CASPubMedWeb of Science®Google Scholar 93 Faber J, Faber OK, Lund B, et al. Hepatic extraction and renal production of 3,3′-diiodothyronine and 3′5′-diiodothyronine in man. J Clin Invest 1980; 66: 941–945. 10.1172/JCI109962 CASPubMedWeb of Science®Google Scholar 94 Gardner DF, Canthers RL Jr, Utiger RD. Thyroid function tests in patients with acute and resolved hepatitis B virus infection. Ann Intern Med 1982; 96: 450–452. 10.7326/0003-4819-96-4-450 CASPubMedWeb of Science®Google Scholar 95 Chopra I, Solomon HD, Chopra U, et al. Alterations in circulating thyroid hormones and thyrotropin in hepatic cirrhosis: evidence for euthyroidism despite subnormal serum triiodothyronine. J Clin Endocrinol Metab 1974; 39: 501–511. 10.1210/jcem-39-3-501 CASPubMedWeb of Science®Google Scholar 96 Schussler GC, Schaffner F, Korn F. Increased serum thyroid hormone binding and decreased free hormone in chronic active liver disease. N Engl J Med 1978; 299: 510–515. 10.1056/NEJM197809072991003 PubMedWeb of Science®Google Scholar 97 Golding PL, Smith M, Williams R. Multisystem involvement in chronic liver disease, studies on the incidence and pathogenesis. Am J Med 1973; 55: 772–782. 10.1016/0002-9343(73)90258-1 PubMedWeb of Science®Google Scholar 98 Israel Y, Walfish PG, Orrego H, et al. Thyroid hormones in alcoholic liver disease. Gastroenterology 1979; 76: 116–122. 10.1016/S0016-5085(79)80137-7 CASPubMedWeb of Science®Google Scholar 99 Kalk WJ, Kew MC, Danilewitz MD, et al. Thyroxine binding globulin and thyroid function tests in patients with hepatocellular carcinoma. Hepatology 1982; 2: 72–76. 10.1002/hep.1840020112 PubMedWeb of Science®Google Scholar 100 Baker A, Kaplan MM, Wolfe H. Central congestive fibrosis in the liver in myxedema ascites. Ann Intern Med 1972; 77: 927–929. 10.7326/0003-4819-77-6-927 PubMedWeb of Science®Google Scholar 101 Beaver DC, Pemberton JD. The pathologic anatomy of the liver in exophthalmic goiter. Ann Intern Med 1933; 7: 687–708. 10.7326/0003-4819-7-6-687 Google Scholar 102 Weller CU. Hepatic pathology in exophthalmic goiter. Ann Intern Med 1933; 7: 543–560. 10.7326/0003-4819-7-5-543 Web of Science®Google Scholar 103 Koff RS. In: Liver disease in primary care medecine, Chapter 6. New York: Appleton-Century-Crofts, 1980: 81–84. Google Scholar 104 Dalovisio JR, Blonde L, Cortez LM, et al. Subacute thyroiditis with increased serum alkaline phosphatase. Ann Intern Med 1978; 88: 505–507. 10.7326/0003-4819-88-4-505 CASPubMedWeb of Science®Google Scholar 105 Cooper DS, Kaplan MM, Ridgway EC, et al. Alkaline phosphatase isoenzyme patterns in hyperthyroidism. Ann Intern Med 1979; 90: 164–168. 10.7326/0003-4819-90-2-164 CASPubMedWeb of Science®Google Scholar 106 Azizi F. γ-Glutamyl transpeptidase levels in thyroid disease. Arch Intern Med 1982; 142: 79–81. 10.1001/archinte.142.1.79 CASPubMedWeb of Science®Google Scholar 107 Ismail-Beigi F, Edelman IS. The mechanism of the calorigenic action of thyroid hormone: stimulation of Na+ and Reactivated adenosinephosphatase activity. J Gen Physiol 1971; 57: 710–722. 10.1085/jgp.57.6.710 CASPubMedWeb of Science®Google Scholar 108 Ya-Pin L, Lardy HA. Influence of thyroid hormones on glycerophosphate dehydrogenases and other dehydrogenases in various organs of the rat. J Biol Chem 1965; 240: 1427–1436. PubMedWeb of Science®Google Scholar 109 Moreno F, Minzlaff K, Hauptmeier H, et al. Alterations of hepatic alcohol metabolizing enzyme activities due to thyroid hormone. Adv Exp Med Biol 1980; 132: 109–115. CASPubMedGoogle Scholar 110 Short J, Brown RF, Husakova A, et al. Induction of DNA synthesis in the liver of the intact animal. J Biol Chem 1972; 247: 1757–1766. CASPubMedWeb of Science®Google Scholar 111 Eichelbaum M, Bodem G, Gupler R, et al. Influence of thyroid status on plasma half-life antipyrene in man. N Engl J Med 1974; 290: 1040–1042. 10.1056/NEJM197405092901902 CASPubMedWeb of Science®Google Scholar 112 Kocen RS, Atkinson M. Ascites in hypothyroidism. Lancet 1963; 1: 520–527. Google Scholar 113 Gartner LM, Arias IM. Hormonal control of hepatic bilirubin transport and conjugation. Am J Physiol 1972; 222: 1091–1099. CASPubMedWeb of Science®Google Scholar 114 Anderson KE, Kappas A. Hormones and liver function: In: L Schiff, ER Schiff, eds. Disease of the liver, 5th ed. Philadelphia: J. B. Lippincott, 1982: 205–211. Google Scholar 115 Linscheer WG, Raheja KL, Cho C, et al. Mechanism of the protective effect of propylthiouracil against acetaminophen (Tylenol) toxicity in the rat. Gastroenterology 1980; 78: 100–107. 10.1016/0016-5085(80)90198-5 CASPubMedWeb of Science®Google Scholar 116 Kalant H, Sereny G, Carlebois R. Evaluation of triiodothyronine in the treatment of acute alcoholic intoxication. N Engl J Med 1962; 267: 1–6. 10.1056/NEJM196207052670101 CASPubMedWeb of Science®Google Scholar 117 Kinkard FW, Hay MG, Kinard JFW. Effect of triiodothyronine on ethanol metabolism in the dog. Nature 1962; 196: 380–381. 10.1038/196380a0 PubMedWeb of Science®Google Scholar 118 Israel Y, Videla L, Fernandez-Videla V, et al. Effects of chronic ethanol treatment and thyroxine administration on ethanol metabolism and liver oxidative capacity. J Pharm Exp Ther 1975; 192: 565–574. CASPubMedWeb of Science®Google Scholar 119 Ugarte G, Peresa T. Influence of hyperthyroidism on the rate of ethanol metabolism in man. Nutr Metab 1978; 22: 113–118. 10.1159/000176204 CASPubMedWeb of Science®Google Scholar 120 Linnoila M, Prinz PN, Wonsowicz CJ, et al. Effect of moderate doses of ethanol and phenobarbital on pituitary and thyroid hormones and testosterone. Br J Addict 1980; 75: 207–212. 10.1111/j.1360-0443.1980.tb02446.x CASPubMedWeb of Science®Google Scholar 121 Murdock HR Jr. Thyroidal effect of alcohol. Q J Stud Alcohol 1967; 28: 419–423. CASPubMedWeb of Science®Google Scholar 122 Oppenheimer JH, Oillman WH, Schwartz H, et al. Nuclear receptors and thyroid hormone action: a progress report. Fed Proc 1979; 38: 2154–2161. CASPubMedWeb of Science®Google Scholar 123 Bernstein J, Videla L, Israel Y. Hormonal influences in the development of the hypermetabolic state of the liver produced by chronic administration of ethanol. J Pharm Exp Ther 1975; 192: 583–591. CASPubMedWeb of Science®Google Scholar 124 Lieber CS. Medical disorders of alcoholism. Pathogenesis and treatment. In: LH Smith, ed. Major problems in internal medicine, Vol XXII. Philadelphia: W. B. Saunders, 1982: 259–312. Google Scholar 125 Britton RS, Koves G, Orrego H, et al. Suppression by antithyroid drugs of experimental hepatic necrosis after ethanol treatment Effect on thyroid gland or on peripheral deiodination?. Toxicol Appl Pharmacol 1979; 51: 145–155. 10.1016/0041-008X(79)90017-6 CASPubMedWeb of Science®Google Scholar 126 Britton RS, Israel Y. Effect of 6-n-propyl-2-thiouracil on the rate of ethanol metabolism in rats treated chronically with ethanol. Biochem Pharmacol 1980; 29: 2951–2955. 10.1016/0006-2952(80)90043-X CASPubMedWeb of Science®Google Scholar 127 Maddrey W. Propylthiouracil treatment of alcoholic hepatitis. Gastroenterology 1979; 76: 218–219. CASPubMedWeb of Science®Google Scholar 128 Kaplowitz N. Propylthiouracil treatment for alcoholic hepatitis: should it and does it work. Gastroenterology 1982; 82: 1468–1472. 10.1016/0016-5085(82)90085-3 CASPubMedWeb of Science®Google Scholar 129 Green WL. Mechanisms of action of antithyroid compounds. In: SC Werner, SH Indbar, eds. The thyroid a fundamental and clinical text, 4th ed. New York: Harper and Row, 1978: 77–87. Google Scholar 130 Moreno F, Petrides AS, Heinen E, et al. Hepatic microsomal ethanol-oxidizing system (MEOS): increased activity following propylthiouracil administration. Alcoholism: Clin Exp Res 1981; 5: 85–91. 10.1111/j.1530-0277.1981.tb04870.x CASPubMedWeb of Science®Google Scholar 131 Grillo MA, Fossa T. Urea synthesis in the liver of the hypothyroid rat. Clin Chim Acta 1966; 13: 383–386. 10.1016/0009-8981(66)90219-1 CASPubMedWeb of Science®Google Scholar 132 Yamada T, Ludwig S, Kuhlenkamp J, et al. Direct protection against acetaminophen hepatotoxicity by propylthiouracil in vivo and in vitro studies in rats and mice. J Clin Invest 1981; 67: 688–695. 10.1172/JCI110084 CASPubMedWeb of Science®Google Scholar 133 Orrego H, Carmichael FJ, Phillips MJ, et al. Protection by propylthiouracil against carbon tetrochloride-induced liver damage. Gastroenterology 1976; 71: 821–826. 10.1016/S0016-5085(76)80367-8 CASPubMedWeb of Science®Google Scholar Citing Literature Volume3, Issue41983Pages 593-600 ReferencesRelatedInformation
Referência(s)